fluoxetine has been researched along with substance p in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, RC; Wang, W | 1 |
| Bertilsson, L; Brodin, E; Mårtensson, B; Nyberg, S; Toresson, G | 1 |
| Dun, NJ; Kiraly, M; Ma, RC | 1 |
| Berti, F; Bianchi, M; Panerai, AE; Rossoni, G; Sacerdote, P | 1 |
| Carlson, EC; de Felipe, C; Harrison, T; Hunt, S; Oates, B; Owen, S; Rupniak, NM; Seward, E; Wheeldon, A | 1 |
| Diaz, J; Lammers, CH; Schwartz, JC; Sokoloff, P | 1 |
| Beverley, JA; Carr, B; Steiner, H; Van Waes, V | 1 |
7 other study(ies) available for fluoxetine and substance p
| Article | Year |
|---|---|
The role of serotonin in non-cholinergic excitatory transmission in the guinea pig inferior mesenteric ganglion.
Topics: Animals; Cyproheptadine; Electric Stimulation; Evoked Potentials; Female; Fluoxetine; Ganglia, Sympathetic; Guinea Pigs; In Vitro Techniques; Male; Membrane Potentials; Myenteric Plexus; Serotonin; Substance P; Synaptic Transmission | 1990 |
Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.
Topics: Adult; Aged; Depressive Disorder; Female; Fluoxetine; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Peptide Fragments; Substance P | 1989 |
Evidence for a serotonin-mediated slow excitatory potential in the guinea-pig coeliac ganglia.
Topics: Action Potentials; Animals; Calcium; Cell Membrane; Cyproheptadine; Fluoxetine; Ganglia, Sympathetic; Guinea Pigs; In Vitro Techniques; Magnesium; Membrane Potentials; Neurons; Parasympatholytics; Serotonin; Substance P; Tryptophan | 1984 |
Effects of chlomipramine and fluoxetine on subcutaneous carrageenin-induced inflammation in the rat.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Carrageenan; Clomipramine; Dinoprostone; Dose-Response Relationship, Drug; Edema; Fluoxetine; Male; Rats; Rats, Sprague-Dawley; Substance P | 1995 |
Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice.
Topics: Animals; Animals, Newborn; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Buspirone; Diazepam; Dose-Response Relationship, Drug; Female; Fluoxetine; Gene Deletion; Guinea Pigs; Imipramine; Injections, Intraventricular; Male; Mice; Mice, Inbred Strains; Motor Activity; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Piperidines; Receptors, Neurokinin-1; Social Isolation; Stress, Psychological; Substance P; Tetrazoles; Vocalization, Animal | 2000 |
Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments.
Topics: Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Desipramine; Dopamine; Dynorphins; Electroshock; Fluoxetine; Gene Expression; Imipramine; Islands of Calleja; Limbic System; Male; Monoamine Oxidase Inhibitors; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Substance P; Tranylcypromine | 2000 |
Fluoxetine potentiation of methylphenidate-induced neuropeptide expression in the striatum occurs selectively in direct pathway (striatonigral) neurons.
Topics: Animals; Autoradiography; Central Nervous System Stimulants; Corpus Striatum; Drug Synergism; Dynorphins; Early Growth Response Protein 1; Enkephalins; Fluoxetine; Gene Expression Regulation; Male; Methylphenidate; Neural Pathways; Neurons; Neuropeptides; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Substance P; Substantia Nigra | 2012 |